Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger)

Bullboard Posts

Post by TriumphSpitSixon Apr 03, 2020 4:20pm

239 Views

Post# 30877471

The fuse is lit.

Another 40k ATBPF in the bag today. I wasn't getting filled at .39 so just hit the ask at .42 right before market close. I usually wait for the ask to come to me but no one is selling down there today and for good reason...

It's extra nerve-wracking with all the pandemic nonsense going on, but we all (well most of us) know the story here and the very high probability of positive results. We could get that news as early as next week, so I pulled the trigger and filled up.

I have officially used up all my gun powder now, so hopefully we see some nice fireworks soon.

Good luck all.

Bullboard Posts

Sirios Resource discovers visible gold in Quebec